In a recent series of cases, the Court of Appeals for the Federal Circuit (CAFC) evaluated whether examples in a patent specification will support infringement of alternative embodiments. Two recent ...

Broad chemical genus claims often represent some of the most valuable assets in a pharmaceutical or chemical patent portfolio. By covering ...

In a recent article, we discussed how courts have used patent specifications in finding that patents satisfy the Supreme Court’s Mayo/Alice test. However, the specification may be a double-edged sword ...

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

A med tech case decided by the PTAB is helpful to inform patent strategy for AI enabled inventions across various disciplines and industries. Patent applicants should expect to see reliance by the ...

“Though these new guidelines may seem unnecessary, there is clear benefit to the public, especially to the applicants who rely on patents for future innovative endeavors.” The United States Patent and ...

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP. Recently, all eyes have ...